• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: BOSTON SCIENTIFIC CORPORATION PROMUS PREMIER; STENT, CORONARY, DRUG-ELUTING

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

BOSTON SCIENTIFIC CORPORATION PROMUS PREMIER; STENT, CORONARY, DRUG-ELUTING Back to Search Results
Model Number 9576
Device Problem Obstruction of Flow (2423)
Patient Problems Angina (1710); High Blood Pressure/ Hypertension (1908); Myocardial Infarction (1969); Restenosis (4576)
Event Date 09/11/2023
Event Type  Injury  
Event Description
It was reported that restenosis occurred.On (b)(6) 2018, the patient presented with unstable angina.Coronary angiography revealed a bifurcated mid left anterior descending artery (lad) with 80-90% disease.The target lesion was directly stented with a 16 x 2.50 promus premier drug eluting stent resulting in 0% residual stenosis.The patient was stable and discharged on dual antiplatelet treatment.On (b)(6) 2023, the patient presented with unstable angina, experiencing left-sided chest pain radiating into the left shoulder and down the left arm for 2 days.Heparin drip was started, and the patient was stable, and their pain was resolved.The patient was diagnosed with non-st-elevation myocardial infraction and hypertension.Vascular access was obtained via the right femoral artery.Angiography revealed 99% in-stent restenosis of the previously deployed promus premier drug eluting stent.Following pre-dilation with a 2.00 x 12 emerge balloon, successful angioplasty was performed using a 2.75 x 22 non-bsc drug eluting stent.Following post dilation there was no residual stenosis.The patient became severely nauseated and hypertensive possibly due to a contrast allergy and was given medication.The patient felt better and was discharged on aspirin and statin therapy.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
PROMUS PREMIER
Type of Device
STENT, CORONARY, DRUG-ELUTING
Manufacturer (Section D)
BOSTON SCIENTIFIC CORPORATION
300 boston scientific way
marlborough MA 01752
Manufacturer (Section G)
BOSTON SCIENTIFIC CORPORATION
ballybrit business park
galway
EI  
Manufacturer Contact
rachel shields
4100 hamline ave n
arden hills, MN 55112
6512422111
MDR Report Key17924951
MDR Text Key325533491
Report Number2124215-2023-56641
Device Sequence Number1
Product Code NIQ
UDI-Device Identifier08714729828860
UDI-Public08714729828860
Combination Product (y/n)Y
Reporter Country CodeUS
PMA/PMN Number
P110010
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type Consumer,Health Professional,Company Representative
Reporter Occupation Physician
Type of Report Initial
Report Date 10/12/2023
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received10/12/2023
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator Health Professional
Device Expiration Date10/08/2018
Device Model Number9576
Device Catalogue Number9576
Device Lot Number0020544881
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Date Manufacturer Received09/21/2023
Was Device Evaluated by Manufacturer? Device Not Returned to Manufacturer
Date Device Manufactured04/11/2017
Is the Device Single Use? Yes
Type of Device Usage Initial
Patient Sequence Number1
Treatment
MEDTRONIC: 2.75 X 22 RESOLUTE ONYX STENT; TERUMO: RUNTHROUGH 6F GUIDE CATHETER
Patient Outcome(s) Required Intervention; Hospitalization;
Patient Age50 YR
Patient SexFemale
Patient Weight60 KG
Patient RaceWhite
-
-